SCHEMBL7430631

SCHEMBL7430631

CC(C)(C)[Si](C)(C)OC1CCCOC1=O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 2/20 0.32
PREP P48147 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9621403 1.00 FKBP1A (0.32) FKBP1APREPPOLB
SCHEMBL26968347 0.89 POLB (0.37) PREPPOLB
SCHEMBL1526521 0.89 POLB (0.37) PREPPOLB
SCHEMBL1526525 0.89 POLB (0.37) PREPPOLB
SCHEMBL8578128 0.75 MAOA (0.34) POLB
SCHEMBL1407014 0.74 CA1 (0.39) POLB
SCHEMBL4559895 0.74 CA1 (0.39) POLB
SCHEMBL10277056 0.74
SCHEMBL10602704 0.73 POLB (0.33) POLB
SCHEMBL20660322 0.71 CCR2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384238-B1 ACYLATION OF STERICALLY HINDERED ALCOHOLS; METAL HALIDE CATALYST LEK PHARMACEUTICAL AND CHEMICAL COMPANY D.D. (SI) 2002-05-07 US claimed
CN-1215064-C A process for producing simvastatin CHEIL JEDANG CORP (KR) 2005-08-17 CN disclosed
EP-1135380-A1 PROCESS FOR THE PREPARATION OF SIMVASTATIN AND ANALOGS THEREOF Lek Pharmaceutical and Chemical Co. D.D. (SI) 2001-09-26 EP disclosed
WO-2000032585-A1 PROCESS FOR THE PREPARATION OF SIMVASTATIN AND ANALOGS THEREOF LEK PHARMACEUTICAL AND CHEMICAL COMPANY D.D. (DE) 2000-06-08 WO disclosed
EP-0444888-B1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one MERCK & CO INC (US) 1995-02-08 EP disclosed
EP-0287340-B1 NOVEL ACYLATION PROCESS FOR THE SYNTHESIS OF HMG-COA REDUCTASE INHIBITORS MERCK & CO. INC. (US) 1993-09-29 EP disclosed
EP-0325817-B1 NOVEL HMG-COA REDUCTASE INHIBITORS MERCK & CO. INC. (US) 1993-05-26 EP disclosed
EP-0327166-B1 NOVEL HMG-COA REDUCTASE INHIBITORS Merck & Co., Inc. (US) 1992-12-30 EP disclosed
EP-0320052-B1 INTERMEDIATES AND PROCESSES FOR 6-CARBOXY HMG-COA REDUCTASE INHIBITORS MERCK & CO. INC. (US) 1992-01-15 EP disclosed
EP-0444888-A1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one MERCK & CO. INC. (US) 1991-09-04 EP disclosed
EP-0331240-A2 Intermediates and processes for beta 6-hydroxymethyl HMG-COA MERCK & CO. INC. (US) 1989-09-06 EP disclosed
EP-0327166-A1 Novel HMG-COA reductase inhibitors MERCK & CO. INC. (US) 1989-08-09 EP disclosed
EP-0327165-A1 HMG-COA reductase inhibitors MERCK & CO. INC. (US) 1989-08-09 EP disclosed
EP-0283123-A2 Intermediates and process useful in the preparation of HMG-COA reductase inhibitors MERCK & CO. INC. (US) 1988-09-21 EP disclosed
US-4450171-A 6-/8-ACYLOXY/POLYHYDRONAPHTH-1-YL/ETHYLENE/ TETRAHYDRO-2H-PYRAN-2- ONE MERCK & CO., INC. (US) 1984-05-22 US disclosed